Immunotherapy- (Blinatumomab-) Related Lineage Switch of <i>KMT2A/AFF1</i> Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia. This evidence concerns the gene AFF1 and myeloid leukemia.